Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobumichi Tanaka

Showing results (21-30 of 290) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Function of JunB in transient amplifying cell senescence and progression of human prostate cancerNoboru Konishi, Keiji Shimada, Mitsutoshi Nakamura, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2022
[The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer]Kenta Onishi, Nobumichi Tanaka, Shunta Hori, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 19, 2013
Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostateTomomi Fujii, Keiji Shimada, Osamu Asai, et al.
BMC Urology|July 24, 2015
Review by urological pathologists improves the accuracy of Gleason grading by general pathologistsYasushi Nakai, Nobumichi Tanaka, Keiji Shimada, et al.
Brachytherapy|October 5, 2024
Prostate-specific antigen (PSA) nadir and experience of PSA bounce after low-dose-rate brachytherapy for prostate cancer predicts clinical failureYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Anticancer Research|December 30, 2022
Effects on Life Expectancy of Treatment Decisions in Patients With Non-metastatic Prostate CancerAkira Tachibana, Shunta Hori, Yasushi Nakai, et al.
Biomedical Research (Tokyo, Japan)|January 7, 2010
A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstructionKatsuya Aoki, Akihide Hirayama, Nobumichi Tanaka, et al.
Cancer Investigation|May 16, 2014
Computer-assisted three-dimensional analysis of multifocal/multicentric prostate cancerTomomi Fujii, Eiwa Ishida, Keiji Shimada, et al.
Radiation Oncology (London, England)|June 3, 2014
The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitionsNobumichi Tanaka, Isao Asakawa, Emiko Katayama, et al.
Pageof 29

Showing results (21-30 of 290) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Function of JunB in transient amplifying cell senescence and progression of human prostate cancerNoboru Konishi, Keiji Shimada, Mitsutoshi Nakamura, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2022
[The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer]Kenta Onishi, Nobumichi Tanaka, Shunta Hori, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 19, 2013
Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostateTomomi Fujii, Keiji Shimada, Osamu Asai, et al.
BMC Urology|July 24, 2015
Review by urological pathologists improves the accuracy of Gleason grading by general pathologistsYasushi Nakai, Nobumichi Tanaka, Keiji Shimada, et al.
Brachytherapy|October 5, 2024
Prostate-specific antigen (PSA) nadir and experience of PSA bounce after low-dose-rate brachytherapy for prostate cancer predicts clinical failureYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Anticancer Research|December 30, 2022
Effects on Life Expectancy of Treatment Decisions in Patients With Non-metastatic Prostate CancerAkira Tachibana, Shunta Hori, Yasushi Nakai, et al.
Biomedical Research (Tokyo, Japan)|January 7, 2010
A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstructionKatsuya Aoki, Akihide Hirayama, Nobumichi Tanaka, et al.
Cancer Investigation|May 16, 2014
Computer-assisted three-dimensional analysis of multifocal/multicentric prostate cancerTomomi Fujii, Eiwa Ishida, Keiji Shimada, et al.
Radiation Oncology (London, England)|June 3, 2014
The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitionsNobumichi Tanaka, Isao Asakawa, Emiko Katayama, et al.
Pageof 29